Elimination of lysosomal storage in brains of MPS VII mice treated by intrathecal administration of an adeno-associated virus vector
Open Access
- 1 June 1999
- journal article
- research article
- Published by Springer Nature in Gene Therapy
- Vol. 6 (6) , 1175-1178
- https://doi.org/10.1038/sj.gt.3300931
Abstract
Mucopolysaccharidosis type VII (MPS VII) is an inherited lysosomal storage disease caused by insufficient β-glucuronidase (GUS). To provide gene therapy in a mutant mouse model of this disease, we have used a recombinant adeno-associated virus (rAAV) vector to deliver GUS cDNA to a variety of tissues. Although intravenous administration of vector produced therapeutic levels of GUS in the liver, delivery to the brain was inadequate. To improve delivery to the brain intrathecal injection of the vector into the cerebrospinal fluid was employed. This route of administration to either neonatal or adult mutant mice resulted in therapeutic levels of GUS in the brain and the elimination of storage granules in brain tissue.Keywords
This publication has 11 references indexed in Scilit:
- Adeno-associated virus vectors can be efficiently produced without helper virusGene Therapy, 1998
- Enzyme replacement therapy for murine mucopolysaccharidosis type VII leads to improvements in behavior and auditory function.Journal of Clinical Investigation, 1998
- Decreased lysosomal storage in the adult MPS VII mouse brain in the vicinity of grafts of retroviral vector-corrected fibroblasts secreting high levels of β-glucuronidaseNature Medicine, 1997
- Gene therapy for lysosomal storage disease: A no-brainer?Nature Medicine, 1997
- Adenovirus-mediated gene transfer and expression of human β-glucuronidase gene in the liver, spleen, and central nervous system in mucopolysaccharidosis type VII miceProceedings of the National Academy of Sciences, 1997
- Efficient transduction of green fluorescent protein in spinal cord neurons using adeno-associated virus vectors containing cell type-specific promotersGene Therapy, 1997
- Enzyme Replacement with Recombinant β-Glucuronidase in the Newborn Mucopolysaccharidosis Type VII MousePediatric Research, 1993
- A single-base-pair deletion in the beta-glucuronidase gene accounts for the phenotype of murine mucopolysaccharidosis type VII.Proceedings of the National Academy of Sciences, 1993
- Murine mucopolysaccharidosis type VII. Characterization of a mouse with beta-glucuronidase deficiency.Journal of Clinical Investigation, 1989
- Beta glucuronidase deficiency: Report of clinical, radiologic, and biochemical features of a new mucopolysaccharidosisThe Journal of Pediatrics, 1973